Ovid Starts Neurology Spree With AstraZeneca Deal

 
• By Alaric DeArment
  
Epilepsy brain
Ovid announced an in-licensing deal with AstraZeneca for a library of KCC2 transporter-targeting drugs • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category